Biologic Drugs With Mechanism of Action: Chemokine Receptor Type 4 Interactions
✉ Email this page to a colleague
Biologic Drugs With Mechanism of Action: Chemokine Receptor Type 4 Interactions
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Kyowa Kirin, Inc. | POTELIGEO | mogamulizumab-kpkc | Injection | 761051 | 2018-08-08 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |